Edwards Lifesciences Corp

NYSE:EWUnited States

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.

Contact Information

Headquarters

1 Edwards WayIRVINE, CA, United States 92614-5688

Phone

949-250-2500

Fax

302-655-5049

Executives

Chairman of the Board, Chief Executive Officer

Michael Mussallem

Chief Financial Officer, Corporate Vice President

Scott Ullem

Corporate Vice President - EMEA (Europe, Middle East and Africa)

Jean-Luc Lemercier

Corporate Vice President - Strategy and Corporate Development

Donald Bobo

Corporate Vice President - Surgical Structural Heart

Daveen Chopra